middle.news
Little Green Pharma FY2026 Revenue Climbs 15% Despite $1.4M Loss on Inventory Hits
10:00am on Thursday 1st of January, 1970 AEST
•
Healthcare
Read Story
Little Green Pharma FY2026 Revenue Climbs 15% Despite $1.4M Loss on Inventory Hits
10:00am on Thursday 1st of January, 1970 AEST
Key Points
FY2026 revenue rises to AUD 42.5 million
Loss after tax of AUD 1.4 million due to inventory write-downs
Adjusted EBITDA jumps to AUD 6.5 million
European sales, especially Germany, drive growth
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Little Green Pharma (ASX:LGP)
OPEN ARTICLE